Cognitive effects of pregabalin in healthy volunteers: A double-blind, placebo-controlled trial

Neurology

Volumn 74, Issue 9, 2010, Pages 755-761

  Salinsky, Martin ^a   Storzbach, Daniel ^a   Munoz, Sonia ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FIBROMYALGIA; HUMAN; NEUROTOXICITY; NORMAL HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; SEIZURE; THOUGHT DISORDER;

EID: 77649257845     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d25b34     Document Type: Article

References (38)

1. Kwan P, Brodie M. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
2. Marson A, Kdir Z, Hutton J, Chadwick D. The new anti-epileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-880. (Pubitemid 27323595)
3. Brodie M, Richens A, Yuen A, et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-479.
4. Mattson RH, Cramer J, Collins J. A comparison of val-proate with carbamazepine for the treatment of partial and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-771.
5. Rowan A, Ramsay R, Collins J, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-1873.
6. Bill P, Vigonious U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine vs. phenytoin in adults with previously untreated epilepsy. Epilepsy Res 1997;27:195-204. (Pubitemid 27306800)
7. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58:s9-s20.
8. Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 2007;17:413-425.
9. Smith D, Mattson R, Cramer J, et al. Results of a nationwide Veterans Administration Cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987; 28(suppl 3):50-58.
10. Meador K, Loring D, Allen M, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537-1540.
11. Meador K, Loring D, Ray P, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;56:1177-1182. (Pubitemid 32405711)
12. Meador K, Gevins A, Loring DW, et al. Neuropsycholog-ical and neurophysiologic effects of effects of carbamaz-epine and levetiracetam. Neurology 2007;69:2076-2084.
13. Salinsky M, Storzbach D, Binder L, Arons C, Dodrill C. Effects of gabapentin and carbamazepine on the EEG, alertness, and cognition in healthy volunteers. Epilepsia 2002;43:482-490.
14. Salinsky M, Storzbach D, Spencer D, Oken B, Landry T, Dodrill C. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005;64:792-798.
15. Beydoun A, Uthman B, Kugler A, et al. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64:475-480.
16. Arroyo S, Anhut H, Kugler A, et al. Pregabalin addon treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45:20-27.
17. French J, Kugler A, Robbins J, Knapp L, Garofalo E. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003;60:1631-1637. (Pubitemid 36618090)
18. Dworkin R, Corbin A, Young J, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-1283.
19. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pre-gabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Pain 2004;110:628-638.
20. Crofford L, Rowbotham M, Mease P, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-1273.
21. Salinsky M, Binder L, Dodrill C, Storzbach D. Test-retest bias, reliability, and regression equations for neuropsycho-logical measures repeated over a 12-16 week interval. J Int Neuropsychol Soc 2001;7:597-605.
22. Reitan R, Wolfram D. The Halstead-Reitan Neuropsy-chological Test Battery. Tucson: Neuropsychology Press; 1985.
23. Lezak M. Neuropsychological Assessment, 3rd ed. New York: Oxford University Press; 1995.
24. Wechsler D. WAIS-R Manual. New York: Psychological Corporation; 1981.
25. Dodrill C. A neuropsychological test battery for epilepsy. Epilepsia 1978;19:611-623.
26. Bushke H, Fuld P. Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 1974;24:1019-1025.
27. Dodrill C. When is computer assisted testing appropriate? In: Dodson W, Kinsbourne M, Hiltbrunner B, eds. The Assessment of Cognitive Function in Epilepsy. New York: Demos; 1991:23-34.
28. Meador K, Loring D, Moore E, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45:1494-1499.
29. Dodrill C. An economical method for the evaluation of general intelligence in adults. J Consult Clin Psychol 1981; 49:668-673.
30. Miller E, Satz P, Visscher B. Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology 1991;41:1608-1616.
31. Benton A, Hamsher K. Multilingual aphasia examination. Iowa City: AJA Associates; 1983.
32. Owsley C, Ball K. Visual impairment and risk of motor vehicle crash among older adults. JAMA 1998;279:1083-1088.
33. Wechsler D. Wechsler Adult Intelligence Scale, 3rd ed. San Antonio: The Psychological Corporation; 1997.
34. McNair D, Lorr M, Dropplemann L. Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1981.
35. Salinsky M, Storzbach D. The Portland Neurotoxicity Scale: validation of a brief self-report measure of antiepi-leptic drug related neurotoxicity. Assessment 2005;12: 107-117.
36. Hindmarch I, Trick L, Ridout F. A double-blind, placebo-and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology 2005;183:133-143.
37. Meador K, Loring D, Ray P, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999; 40:1279-1285.
38. Salinsky M, Spencer D, Oken B, Storzbach D. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav 2004;5:894-902.